283 related articles for article (PubMed ID: 7304632)
1. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
[TBL] [Abstract][Full Text] [Related]
2. Plasma salicylate concentrations following chronic administration of aspirin as conventional and sustained-release tablets.
Wiseman EH
Curr Ther Res Clin Exp; 1969 Nov; 11(11):681-9. PubMed ID: 4982303
[No Abstract] [Full Text] [Related]
3. Interaction of omeprazole with enteric-coated salicylate tablets.
Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
[TBL] [Abstract][Full Text] [Related]
4. Comparative bioavailability of sustained-release and conventional tablets of hydroxyethyltheophylline in man.
Sharma PL; Sharma RM
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):394-6. PubMed ID: 583044
[TBL] [Abstract][Full Text] [Related]
5. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
Taggart WV; Holyoak W
Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
[TBL] [Abstract][Full Text] [Related]
6. The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets.
Jonkman JH; van der Boon WJ; Schoenmaker R; Holtkamp A; Thürkow-Luikens AJ
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):506-10. PubMed ID: 6500770
[TBL] [Abstract][Full Text] [Related]
7. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
Latini R; Cerletti C; de Gaetano G; Dejana E; Galletti F; Urso R; Marzot M
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):313-8. PubMed ID: 3733281
[TBL] [Abstract][Full Text] [Related]
8. Absorption of theophylline from conventional and sustained-release tablets.
Fagerström PO; Mellstrand T; Svedmyr N
Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):131-8. PubMed ID: 7228455
[TBL] [Abstract][Full Text] [Related]
9. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
Nap RC; Breen DJ; Lam TJ; Peters IO; Willemsen A; De Bruyne JJ
Tijdschr Diergeneeskd; 1993 Jul; 118(13):439-42. PubMed ID: 8346511
[TBL] [Abstract][Full Text] [Related]
10. Absorption of theophylline from conventional and sustained-release tablets.
Mellstrand T; Svedmyr N; Fagerström PO
Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
[TBL] [Abstract][Full Text] [Related]
11. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
12. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
Portek I; Graham G; Fleming A
Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
[TBL] [Abstract][Full Text] [Related]
13. Effects of different aspirin formulations on platelet aggregation times and on plasma salicylate concentrations.
Schwertner HA; McGlasson D; Christopher M; Bush AC
Thromb Res; 2006; 118(4):529-34. PubMed ID: 16298420
[TBL] [Abstract][Full Text] [Related]
14. Serum salicylate concentrations and endoscopic evaluation of the gastric mucosa in dogs after oral administration of aspirin-containing products.
Lipowitz AJ; Boulay JP; Klausner JS
Am J Vet Res; 1986 Jul; 47(7):1586-9. PubMed ID: 3740630
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
[TBL] [Abstract][Full Text] [Related]
16. Single-dose evaluation of a new enteric-coated aspirin preparation.
Paull P; Day R; Graham G; Champion D
Med J Aust; 1976 Apr; 1(17):617-9. PubMed ID: 933973
[TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics of fluvastatin in healthy subjects following a new extended release fluvastatin tablet, Lescol XL.
Barilla D; Prasad P; Hubert M; Gumbhir-Shah K
Biopharm Drug Dispos; 2004 Mar; 25(2):51-9. PubMed ID: 14872552
[TBL] [Abstract][Full Text] [Related]
18. Dipyridamole bioavailability in subjects with reduced gastric acidity.
Derendorf H; VanderMaelen CP; Brickl RS; MacGregor TR; Eisert W
J Clin Pharmacol; 2005 Jul; 45(7):845-50. PubMed ID: 15951475
[TBL] [Abstract][Full Text] [Related]
19. Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.
Rojanasthien N; Chaichana N; Teekachunhatean S; Kumsorn B; Sangdee C; Chankrachang S
J Med Assoc Thai; 2007 Sep; 90(9):1883-93. PubMed ID: 17957935
[TBL] [Abstract][Full Text] [Related]
20. Steady-state plasma levels of salicylate in patients with rheumatoid arthritis: effects of dosing interval and tablet strength.
Keystone EC; Paton TW; Littlejohn G; Verdejo A; Piper S; Wright LA; Goldsmith CH
Can Med Assoc J; 1982 Aug; 127(4):283-6. PubMed ID: 7093867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
